PFIZER
Back to Balance Sheet
|
PFIZER Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹156 Cr | ₹176 Cr | ₹437 Cr | ₹548 Cr | ₹467 Cr |
What is the latest Contingent Liabilities ratio of PFIZER ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹156 Cr |
| Mar2024 | ₹176 Cr |
| Mar2023 | ₹437 Cr |
| Mar2022 | ₹548 Cr |
| Mar2021 | ₹467 Cr |
How is Contingent Liabilities of PFIZER Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹156 Cr | -11.64 | |
| Mar2024 | ₹176 Cr | -59.62 | |
| Mar2023 | ₹437 Cr | -20.37 | |
| Mar2022 | ₹548 Cr | 17.47 | |
| Mar2021 | ₹467 Cr | - | |
Compare Contingent Liabilities of peers of PFIZER
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PFIZER | ₹22,809.3 Cr | 0.2% | -4.2% | -6.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹431,412.0 Cr | -0.4% | 6.4% | 4.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,343.0 Cr | -1.5% | -4.9% | 7.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹126,191.0 Cr | -0.7% | 4.8% | 16.6% | Stock Analytics | |
| CIPLA | ₹122,511.0 Cr | -0.5% | 1% | 2.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,523.0 Cr | 2.2% | 6.6% | 5.7% | Stock Analytics | |
PFIZER Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PFIZER | 0.2% |
-4.2% |
-6.3% |
| SENSEX | 0.7% |
0.9% |
6.1% |
You may also like the below Video Courses